Skip to main content
DARE
NASDAQ Life Sciences

NIH Extends $2M Non-Dilutive Grant for Daré Bioscience's Preterm Birth Drug Candidate

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.468
Mkt Cap
$20.576M
52W Low
$1.42
52W High
$9.19
52W Position info
3.4% above low
Off High info
84% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

DARE is trading near its 52-week low of $1.42 (3.4% above the low).

Summary

Daré Bioscience announced it received an extended Notice of Award from the NIH, securing approximately $2.0 million in non-dilutive funding for its DARE-PTB1 program. This extension specifically covers the second tranche of approximately $1.0 million through November 2026, ensuring continued support for the Phase 1 clinical study of its novel intravaginal ring for preterm birth prevention. For a company with a market capitalization of around $20 million, this $2 million in non-dilutive funding is highly material, representing a significant portion of its value and substantially de-risking the development of a key pipeline asset without shareholder dilution. This news is new and not reflected in the recent SEC filings. Traders will monitor the progress of the DARE-PTB1 clinical study and any further updates on its development.

At the time of this announcement, DARE was trading at $1.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.6M. The 52-week trading range was $1.42 to $9.19. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

DARE - Latest Insights

DARE
Oct 06, 2026, 5:00 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.844
Real-time Price: $0.417 info
Change: -$0.427 (-51%) info
Market Cap: $8.014M info
DARE
Oct 02, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.8428
Real-time Price: $0.417 info
Change: -$0.4258 (-51%) info
Market Cap: $8.014M info
DARE
Sep 23, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.8074
Real-time Price: $0.417 info
Change: -$0.3904 (-48%) info
Market Cap: $8.014M info
DARE
Aug 26, 2026, 5:15 PM EDT
Filing Type: S-1
Importance Score:
7
Price at Filing: $0.810
Real-time Price: $0.417 info
Change: -$0.393 (-49%) info
Market Cap: $8.014M info
DARE
Aug 17, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.900
Real-time Price: $0.417 info
Change: -$0.483 (-54%) info
Market Cap: $8.014M info